A CONTROLLED, IN VIVO, PILOT STUDY TO ASSESS THE RECOVERY AND SURVIVAL OF RADIOLABELED AUTOLOGOUS INTERCEPT TREATED 7-DAY STORED APHERESIS PLATELET COMPONENTS IN 35% PLASMA AND 65% INTERSOL AND 7-DAY STORED APHERESIS PLATELET COMPONENTS IN 100% PLASMA: